WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/108584    International Application No.:    PCT/CN2005/000639
Publication Date: 17.11.2005 International Filing Date: 09.05.2005
A61K 48/00 (2006.01), A61P 35/00 (2006.01), A61P 37/04 (2006.01), C12N 15/19 (2006.01), C12N 15/62 (2006.01), C12N 15/63 (2006.01)
Applicants: DONGGUAN HAOFA BIO-ENGINEERING DEVELOPMENT CO., LTD. [CN/CN]; Nearby Baishikeng Village, Houjie Town, DongGuan City, Guangdong 523450 (CN) (For All Designated States Except US).
ZHANG, Shuren [CN/CN]; (CN) (For US Only).
LIN, Chen [CN/CN]; (CN) (For US Only).
SUN, Wenxin [CN/CN]; (CN) (For US Only).
TAN, Hanjun [CN/CN]; (CN) (For US Only).
ZHOU, Chunxia [CN/CN]; (CN) (For US Only).
LIANG, Xiao [CN/CN]; (CN) (For US Only).
WANG, Dongmei [CN/CN]; (CN) (For US Only).
MA, Wenbo [CN/CN]; (CN) (For US Only).
ZHANG, Xueyan [CN/CN]; (CN) (For US Only).
FU, Ming [CN/CN]; (CN) (For US Only)
Inventors: ZHANG, Shuren; (CN).
LIN, Chen; (CN).
SUN, Wenxin; (CN).
TAN, Hanjun; (CN).
ZHOU, Chunxia; (CN).
LIANG, Xiao; (CN).
WANG, Dongmei; (CN).
MA, Wenbo; (CN).
ZHANG, Xueyan; (CN).
FU, Ming; (CN)
Agent: JEEKAI & PARTNERS; Suite 602, Jinyu Tower, A129 West Xuan Wu Men Street, Beijing 100031 (CN)
Priority Data:
200410037910.3 10.05.2004 CN
Abstract: front page image
(EN)The present invention provides a recombinant gene sequence; which comprising the human SLC gene, the antigen gene and the gene of Fc fragment of IgGI, wherein the SLC gene and the gene of Fc fragment are linking to the upstream and downstream of the antigen gene, respectively. The use of the recombinant gene in the preparation of vaccine is also provided.
(FR)La présente invention concerne une séquence génique recombinante, qui comprend le gène humain SLC, le gène antigène et le gène du fragment Fc d'IgGI. Le gène SLC et le gène du fragment Fc sont liés en amont et en aval du gène antigène, respectivement. L'invention concerne également l'utilisation du gène recombinant dans la préparation d'un vaccin.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)